Highlight Events

Virtual KOL event to review lete-cel final data and discuss sarcoma franchise, Monday, November 18, 2024; 2:30 PM EST

Adaptimmune will host a virtual event to review the IGNYTE-ESO dataset and the impact of engineered cell therapies on the treatment landscape in sarcoma. The event will feature Dr. Sandra D’Angelo, sarcoma medical oncologist of Memorial Sloan Kettering Cancer Center, an investigating clinician in both the SPEARHEAD and IGNYTE-ESO clinical trials.

Adaptimmune Investor Day

April 18th, 2024

Presentation Replay - Part 1 Replay - Part 2 Replay - Part 3